Carregant...
Changes of serum midkine as a dynamic prognostic factor to monitor disease status in papillary thyroid cancer
This study aimed to investigate the value of dynamic changes of midkine (MK) to monitor post-surgical patients with papillary thyroid cancer (PTC) who were managed with (131)I therapies. MK concentration at initial (131)I ablation therapy (MK1) as well as 10 to 12 months thereafter (MK2) was evaluat...
Guardat en:
| Publicat a: | Medicine (Baltimore) |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer Health
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6133610/ https://ncbi.nlm.nih.gov/pubmed/30200153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000012242 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|